Siedlce, Poland

Krzysztof Kurowski



Average Co-Inventor Count = 7.9

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2007-2011

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Mind of Krzysztof Kurowski

Introduction

Krzysztof Kurowski is a distinguished inventor based in Siedlce, Poland, known for his contributions to the field of medicinal chemistry. With a portfolio of five patents, he has made significant strides in developing novel compounds that show promise as therapeutic agents.

Latest Patents

Krzysztof's latest patents focus on 3-phenylpropionic acid derivatives. The first patent describes new compounds that function as ligands for the PPAR-gamma receptor, which are important in various medical applications. These compounds are characterized by a specific formula (I), where different groups like W, Y, Z, and X define their chemical structure. Additionally, he has invented a method for treating diseases mediated by the PPAR-gamma receptor, involving the administration of these compounds in effective amounts. These innovations highlight his commitment to advancing medical science and improving therapeutic options for patients.

Career Highlights

Krzysztof works at Adamed Sp. Z O.o., where he continues to push the boundaries of research and development in pharmaceuticals. His focus on PPAR-gamma receptor ligands showcases his dedication to exploring novel treatments for various diseases, furthering the field of medicinal chemistry.

Collaborations

Throughout his career, Krzysztof has collaborated with notable colleagues such as Zbigniew Majka and Katarzyna Ewa Rusin. These partnerships have likely contributed to his innovative approach, fostering an environment where groundbreaking ideas can flourish.

Conclusion

Krzysztof Kurowski's inventive work and his commitment to therapeutic advancements position him as a valuable contributor to the scientific community. His patents not only signify individual achievement but also pave the way for future innovations in the treatment of diseases. As he continues his work at Adamed, the impact of his research is expected to grow, benefiting both the field of medicinal chemistry and patients in need of effective treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…